Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hare

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Blood|December 15, 1990
Vampire bat salivary plasminogen activator is quiescent in human plasma in the absence of fibrin unlike human tissue plasminogen activatorS J Gardell, T R Hare, P W Bergum, et al.
Protein Science : a Publication of the Protein Society|November 1, 1992
Solution-state structure by NMR of zinc-substituted rubredoxin from the marine hyperthermophilic archaebacterium Pyrococcus furiosusP R Blake, J B Park, Z H Zhou, et al.
The Journal of Antibiotics|July 1, 1989
Sch 38519, a novel platelet aggregation inhibitor produced by a Thermomonospora sp. Taxonomy, fermentation, isolation, physico-chemical properties, structure and biological propertiesM Patel, V Hegde, A Horan, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpointG L Drusano, S L Preston, C Hardalo, et al.
Chemosphere|August 14, 2020
Relationship between the Pacific Decadal Oscillation (PDO) and persistent organic pollutants in sympatric Alaskan seabird (<i>Uria aalge</i> and <i>U. lomvia</i>) eggs between 1999 and 2010Vrinda Kalia, Stacy S Schuur, Keith A Hobson, et al.
Thrombosis and Haemostasis|March 1, 1995
Vampire bat salivary plasminogen activator evokes minimal bleeding relative to tissue-type plasminogen activator as assessed by a rabbit cuticle bleeding time modelM J Mellott, D R Ramjit, I I Stabilito, et al.
BMJ (Clinical Research Ed.)|November 16, 2002
Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological studyR C Davis, F D R Hobbs, J E Kenkre, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeastsF Sabatelli, R Patel, P A Mann, et al.
Infection and Immunity|November 18, 2000
Immunomodulatory role of endogenous interleukin-18 in gamma interferon-mediated resolution of replicative Legionella pneumophila lung infectionJ K Brieland, C Jackson, S Hurst, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
In vitro uptake of SCH 27899 (evernimicin) by rat alveolar macrophagesS Zbaida, J Brieland, P Krieter, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Blood|December 15, 1990
Vampire bat salivary plasminogen activator is quiescent in human plasma in the absence of fibrin unlike human tissue plasminogen activatorS J Gardell, T R Hare, P W Bergum, et al.
Protein Science : a Publication of the Protein Society|November 1, 1992
Solution-state structure by NMR of zinc-substituted rubredoxin from the marine hyperthermophilic archaebacterium Pyrococcus furiosusP R Blake, J B Park, Z H Zhou, et al.
The Journal of Antibiotics|July 1, 1989
Sch 38519, a novel platelet aggregation inhibitor produced by a Thermomonospora sp. Taxonomy, fermentation, isolation, physico-chemical properties, structure and biological propertiesM Patel, V Hegde, A Horan, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpointG L Drusano, S L Preston, C Hardalo, et al.
Chemosphere|August 14, 2020
Relationship between the Pacific Decadal Oscillation (PDO) and persistent organic pollutants in sympatric Alaskan seabird (<i>Uria aalge</i> and <i>U. lomvia</i>) eggs between 1999 and 2010Vrinda Kalia, Stacy S Schuur, Keith A Hobson, et al.
Thrombosis and Haemostasis|March 1, 1995
Vampire bat salivary plasminogen activator evokes minimal bleeding relative to tissue-type plasminogen activator as assessed by a rabbit cuticle bleeding time modelM J Mellott, D R Ramjit, I I Stabilito, et al.
BMJ (Clinical Research Ed.)|November 16, 2002
Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological studyR C Davis, F D R Hobbs, J E Kenkre, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeastsF Sabatelli, R Patel, P A Mann, et al.
Infection and Immunity|November 18, 2000
Immunomodulatory role of endogenous interleukin-18 in gamma interferon-mediated resolution of replicative Legionella pneumophila lung infectionJ K Brieland, C Jackson, S Hurst, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
In vitro uptake of SCH 27899 (evernimicin) by rat alveolar macrophagesS Zbaida, J Brieland, P Krieter, et al.
Pageof 14